Democratising Automated Compound Screening Strategies in Early Drug Discovery
Treherne J. Mark · Journal of Robotics and Automation · 2022
Novel drugs are continuing to bring improved health benefits to an increasing number of patients. However, the costs of delivering these new treatments continue to grow year by year. Pharmaceutical companies often justify these increasing reimbursement costs based on the persistently high attrition rate of promising new compounds failing through the lengthy drug discovery process.